POMALIDOMIDE for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 50 adverse event reports in the FDA FAERS database where POMALIDOMIDE was used for Prostate cancer.
Most Reported Side Effects for POMALIDOMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 7,023 | 7.6% | 3,048 | 1,311 |
| Death | 6,795 | 7.4% | 6,792 | 495 |
| Fatigue | 6,530 | 7.1% | 148 | 811 |
| Pneumonia | 5,792 | 6.3% | 653 | 4,576 |
| Off label use | 3,845 | 4.2% | 388 | 826 |
| Diarrhoea | 3,351 | 3.6% | 140 | 720 |
| White blood cell count decreased | 3,328 | 3.6% | 85 | 686 |
| Neutropenia | 3,029 | 3.3% | 386 | 944 |
| Rash | 2,715 | 2.9% | 47 | 273 |
| Dyspnoea | 2,543 | 2.8% | 145 | 890 |
| Neuropathy peripheral | 2,382 | 2.6% | 74 | 248 |
| Constipation | 2,374 | 2.6% | 52 | 334 |
| Asthenia | 2,300 | 2.5% | 117 | 715 |
| Nausea | 2,045 | 2.2% | 100 | 362 |
| Product dose omission issue | 1,961 | 2.1% | 7 | 174 |
Other Indications for POMALIDOMIDE
Plasma cell myeloma (81,096)
Product used for unknown indication (4,764)
Plasma cell myeloma recurrent (2,809)
Plasma cell myeloma refractory (1,562)
Plasma cell myeloma in remission (1,379)
Amyloidosis (477)
Off label use (434)
Kaposi's sarcoma (268)
Plasma cell leukaemia (209)
Plasmacytoma (191)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)